Elegen

Menlo Park, CA · Founded 2017 · Privately Held (backing)

Developer of microfluidics technology designed to disrupt synthetic biology. Elegen is based in Menlo Park, CA and was founded in 2017. Its last known valuation is $100 million. It has raised $56.6 million across 1 recorded round; the latest was a $33 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$100.0M
Total raised
$56.6M
Last round
Early Stage VC
May 2024

Who backs Elegen?

17 investors
InvestorType
Y CombinatorOther
Andreessen HorowitzVenture capital
8VCVenture capital
National Institutes of HealthOther
In-Q-TelVenture capital
Raptor GroupVenture capital
AME Cloud VenturesVenture capital
EDBIVenture capital
Digitalis VenturesVenture capital
ATEL Capital GroupAsset manager
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Elegen investors

17 investors are on record for Elegen, including Y Combinator, Andreessen Horowitz, 8VC and National Institutes of Health. By type, the record holds 7 venture capital firms and 1 asset manager. The early-stage round in May 2024 drew 28 investors.

Free account
More of Elegen with a free account
  • ·The complete investor list: 17 names
  • ·Watch Elegen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Elegen. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View